The role of Rac1 in the regulation of NF-kB activity, cell proliferation, and cell migration in non-small cell lung carcinoma

References

• Bosco EE, Mulloy JC, Zheng Y. Rac1 GTPase: a “Rac” of all trades. Cell Mol Life Sci 2009; 66:370 - 4; http://dx.doi.org/10.1007/s00018-008-8552-x; PMID: 19151919
   PubMed Web of Science ®Google Scholar
• Vega FM, Ridley AJ. Rho GTPases in cancer cell biology. FEBS Lett 2008; 582:2093 - 101; http://dx.doi.org/10.1016/j.febslet.2008.04.039; PMID: 18460342
   PubMed Web of Science ®Google Scholar
• Kissil JL, Walmsley MJ, Hanlon L, Haigis KM, Bender Kim CF, Sweet-Cordero A, et al. Requirement for Rac1 in a K-ras induced lung cancer in the mouse. Cancer Res 2007; 67:8089 - 94; http://dx.doi.org/10.1158/0008-5472.CAN-07-2300; PMID: 17804720
   PubMed Web of Science ®Google Scholar
• Westwick JK, Lambert QT, Clark GJ, Symons M, Van Aelst L, Pestell RG, et al. Rac regulation of transformation, gene expression, and actin organization by multiple, PAK-independent pathways. Mol Cell Biol 1997; 17:1324 - 35; PMID: 9032259
   PubMed Web of Science ®Google Scholar
• Qiu RG, Chen J, Kirn D, McCormick F, Symons M. An essential role for Rac in Ras transformation. Nature 1995; 374:457 - 9; http://dx.doi.org/10.1038/374457a0; PMID: 7700355
   PubMed Web of Science ®Google Scholar
• Liu Y, Wang Y, Zhang Y, Miao Y, Zhao Y, Zhang PX, et al. Abnormal expression of p120-catenin, E-cadherin, and small GTPases is significantly associated with malignant phenotype of human lung cancer. Lung Cancer 2009; 63:375 - 82; http://dx.doi.org/10.1016/j.lungcan.2008.12.012; PMID: 19162367
   PubMed Web of Science ®Google Scholar
• Schnelzer A, Prechtel D, Knaus U, Dehne K, Gerhard M, Graeff H, et al. Rac1 in human breast cancer: overexpression, mutation analysis, and characterization of a new isoform, Rac1b. Oncogene 2000; 19:3013 - 20; http://dx.doi.org/10.1038/sj.onc.1203621; PMID: 10871853
   PubMed Web of Science ®Google Scholar
• Fritz G, Just I, Kaina B. Rho GTPases are over-expressed in human tumors. Int J Cancer 1999; 81:682 - 7; http://dx.doi.org/10.1002/(SICI)1097-0215(19990531)81:5<682::AID-IJC2>3.0.CO;2-B; PMID: 10328216
   PubMed Web of Science ®Google Scholar
• Jordan P, Brazåo R, Boavida MG, Gespach C, Chastre E. Cloning of a novel human Rac1b splice variant with increased expression in colorectal tumors. Oncogene 1999; 18:6835 - 9; http://dx.doi.org/10.1038/sj.onc.1203233; PMID: 10597294
   PubMed Web of Science ®Google Scholar
• Yuan K, Qian C, Zheng R. Prognostic significance of immunohistochemical Rac1 expression in survival in early operable non-small cell lung cancer. Med Sci Monit 2009; 15:BR313 - 9; PMID: 19865048
   PubMedGoogle Scholar
• Baud V, Karin M. Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls. Nat Rev Drug Discov 2009; 8:33 - 40; http://dx.doi.org/10.1038/nrd2781; PMID: 19116625
   PubMed Web of Science ®Google Scholar
• Karin M. Nuclear factor-kappaB in cancer development and progression. Nature 2006; 441:431 - 6; http://dx.doi.org/10.1038/nature04870; PMID: 16724054
   PubMed Web of Science ®Google Scholar
• Bassères DS, Baldwin AS. Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression. Oncogene 2006; 25:6817 - 30; http://dx.doi.org/10.1038/sj.onc.1209942; PMID: 17072330
   PubMed Web of Science ®Google Scholar
• Hayden MS, Ghosh S. Signaling to NF-kappaB. Genes Dev 2004; 18:2195 - 224; http://dx.doi.org/10.1101/gad.1228704; PMID: 15371334
   PubMed Web of Science ®Google Scholar
• Ghosh S, Karin M. Missing pieces in the NF-kappaB puzzle. Cell 2002; 109:Suppl S81 - 96; http://dx.doi.org/10.1016/S0092-8674(02)00703-1; PMID: 11983155
   PubMed Web of Science ®Google Scholar
• Karin M, Lin A. NF-kappaB at the crossroads of life and death. Nat Immunol 2002; 3:221 - 7; http://dx.doi.org/10.1038/ni0302-221; PMID: 11875461
   PubMed Web of Science ®Google Scholar
• Arbibe L, Mira JP, Teusch N, Kline L, Guha M, Mackman N, et al. Toll-like receptor 2-mediated NF-kappa B activation requires a Rac1-dependent pathway. Nat Immunol 2000; 1:533 - 40; http://dx.doi.org/10.1038/82797; PMID: 11101877
   PubMed Web of Science ®Google Scholar
• Sulciner DJ, Irani K, Yu ZX, Ferrans VJ, Goldschmidt-Clermont P, Finkel T. rac1 regulates a cytokine-stimulated, redox-dependent pathway necessary for NF-kappaB activation. Mol Cell Biol 1996; 16:7115 - 21; PMID: 8943367
   PubMed Web of Science ®Google Scholar
• Chaturvedi MM, Sung B, Yadav VR, Kannappan R, Aggarwal BB. NF-κB addiction and its role in cancer: ‘one size does not fit all’. Oncogene 2011; 30:1615 - 30; http://dx.doi.org/10.1038/onc.2010.566; PMID: 21170083
   PubMed Web of Science ®Google Scholar
• Justilien V, Fields AP. Ect2 links the PKCiota-Par6alpha complex to Rac1 activation and cellular transformation. Oncogene 2009; 28:3597 - 607; http://dx.doi.org/10.1038/onc.2009.217; PMID: 19617897
   PubMed Web of Science ®Google Scholar
• Chen QY, Xu LQ, Jiao DM, Yao QH, Wang YY, Hu HZ, et al. Silencing of Rac1 modifies lung cancer cell migration, invasion and actin cytoskeleton rearrangements and enhances chemosensitivity to antitumor drugs. Int J Mol Med 2011; 28:769 - 76; PMID: 21837360
   PubMed Web of Science ®Google Scholar
• Jayachandran G, Sazaki J, Nishizaki M, Xu K, Girard L, Minna JD, et al. Fragile histidine triad-mediated tumor suppression of lung cancer by targeting multiple components of the Ras/Rho GTPase molecular switch. Cancer Res 2007; 67:10379 - 88; http://dx.doi.org/10.1158/0008-5472.CAN-07-0677; PMID: 17974981
   PubMed Web of Science ®Google Scholar
• Gao Y, Dickerson JB, Guo F, Zheng J, Zheng Y. Rational design and characterization of a Rac GTPase-specific small molecule inhibitor. Proc Natl Acad Sci U S A 2004; 101:7618 - 23; http://dx.doi.org/10.1073/pnas.0307512101; PMID: 15128949
   PubMed Web of Science ®Google Scholar
• Pierce JW, Schoenleber R, Jesmok G, Best J, Moore SA, Collins T, et al. Novel inhibitors of cytokine-induced IkappaBalpha phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. J Biol Chem 1997; 272:21096 - 103; http://dx.doi.org/10.1074/jbc.272.34.21096; PMID: 9261113
   PubMed Web of Science ®Google Scholar
• Gasparian AV, Guryanova OA, Chebotaev DV, Shishkin AA, Yemelyanov AY, Budunova IV. Targeting transcription factor NFkappaB: comparative analysis of proteasome and IKK inhibitors. Cell Cycle 2009; 8:1559 - 66; http://dx.doi.org/10.4161/cc.8.10.8415; PMID: 19372735
   PubMed Web of Science ®Google Scholar
• Page K, Li J, Hodge JA, Liu PT, Vanden Hoek TL, Becker LB, et al. Characterization of a Rac1 signaling pathway to cyclin D(1) expression in airway smooth muscle cells. J Biol Chem 1999; 274:22065 - 71; http://dx.doi.org/10.1074/jbc.274.31.22065; PMID: 10419534
   PubMed Web of Science ®Google Scholar
• Olson MF, Ashworth A, Hall A. An essential role for Rho, Rac, and Cdc42 GTPases in cell cycle progression through G1. Science 1995; 269:1270 - 2; http://dx.doi.org/10.1126/science.7652575; PMID: 7652575
   PubMed Web of Science ®Google Scholar
• Miyano K, Ueno N, Takeya R, Sumimoto H. Direct involvement of the small GTPase Rac in activation of the superoxide-producing NADPH oxidase Nox1. J Biol Chem 2006; 281:21857 - 68; http://dx.doi.org/10.1074/jbc.M513665200; PMID: 16762923
   PubMed Web of Science ®Google Scholar
• Moldovan L, Mythreye K, Goldschmidt-Clermont PJ, Satterwhite LL. Reactive oxygen species in vascular endothelial cell motility. Roles of NAD(P)H oxidase and Rac1. Cardiovasc Res 2006; 71:236 - 46; http://dx.doi.org/10.1016/j.cardiores.2006.05.003; PMID: 16782079
   PubMed Web of Science ®Google Scholar
• Denlinger CE, Rundall BK, Jones DR. Modulation of antiapoptotic cell signaling pathways in non-small cell lung cancer: the role of NF-kappaB. Semin Thorac Cardiovasc Surg 2004; 16:28 - 39; http://dx.doi.org/10.1053/j.semtcvs.2003.12.004; PMID: 15366685
   PubMedGoogle Scholar
• Sun D, Xu D, Zhang B. Rac signaling in tumorigenesis and as target for anticancer drug development. Drug Resist Updat 2006; 9:274 - 87; http://dx.doi.org/10.1016/j.drup.2006.12.001; PMID: 17234445
   PubMed Web of Science ®Google Scholar
• Chiariello M, Marinissen MJ, Gutkind JS. Regulation of c-myc expression by PDGF through Rho GTPases. Nat Cell Biol 2001; 3:580 - 6; http://dx.doi.org/10.1038/35078555; PMID: 11389443
   PubMed Web of Science ®Google Scholar
• Aznar S, Lacal JC. Rho signals to cell growth and apoptosis. Cancer Lett 2001; 165:1 - 10; http://dx.doi.org/10.1016/S0304-3835(01)00412-8; PMID: 11248412
   PubMed Web of Science ®Google Scholar
• Moore KA, Sethi R, Doanes AM, Johnson TM, Pracyk JB, Kirby M, et al. Rac1 is required for cell proliferation and G2/M progression. Biochem J 1997; 326:17 - 20; PMID: 9337845
   PubMed Web of Science ®Google Scholar
• Michaelson D, Abidi W, Guardavaccaro D, Zhou M, Ahearn I, Pagano M, et al. Rac1 accumulates in the nucleus during the G2 phase of the cell cycle and promotes cell division. J Cell Biol 2008; 181:485 - 96; http://dx.doi.org/10.1083/jcb.200801047; PMID: 18443222
   PubMed Web of Science ®Google Scholar
• Abe K, Rossman KL, Liu B, Ritola KD, Chiang D, Campbell SL, et al. Vav2 is an activator of Cdc42, Rac1, and RhoA. J Biol Chem 2000; 275:10141 - 9; http://dx.doi.org/10.1074/jbc.275.14.10141; PMID: 10744696
   PubMed Web of Science ®Google Scholar
• Miyamoto Y, Yamauchi J, Sanbe A, Tanoue A. Dock6, a Dock-C subfamily guanine nucleotide exchanger, has the dual specificity for Rac1 and Cdc42 and regulates neurite outgrowth. Exp Cell Res 2007; 313:791 - 804; http://dx.doi.org/10.1016/j.yexcr.2006.11.017; PMID: 17196961
   PubMed Web of Science ®Google Scholar
• Kulkarni K, Yang J, Zhang Z, Barford D. Multiple factors confer specific Cdc42 and Rac protein activation by dedicator of cytokinesis (DOCK) nucleotide exchange factors. J Biol Chem 2011; 286:25341 - 51; http://dx.doi.org/10.1074/jbc.M111.236455; PMID: 21613211
   PubMed Web of Science ®Google Scholar
• Jiang Y, Cui L, Yie TA, Rom WN, Cheng H, Tchou-Wong KM. Inhibition of anchorage-independent growth and lung metastasis of A549 lung carcinoma cells by IkappaBbeta. Oncogene 2001; 20:2254 - 63; http://dx.doi.org/10.1038/sj.onc.1204293; PMID: 11402320
   PubMed Web of Science ®Google Scholar
• Wu K, Bonavida B. The activated NF-kappaB-Snail-RKIP circuitry in cancer regulates both the metastatic cascade and resistance to apoptosis by cytotoxic drugs. Crit Rev Immunol 2009; 29:241 - 54; PMID: 19538137
   PubMed Web of Science ®Google Scholar
• Royuela M, Rodríguez-Berriguete G, Fraile B, Paniagua R. TNF-alpha/IL-1/NF-kappaB transduction pathway in human cancer prostate. Histol Histopathol 2008; 23:1279 - 90; PMID: 18712680
   PubMed Web of Science ®Google Scholar
• Brown M, Cohen J, Arun P, Chen Z, Van Waes C. NF-kappaB in carcinoma therapy and prevention. Expert Opin Ther Targets 2008; 12:1109 - 22; http://dx.doi.org/10.1517/14728222.12.9.1109; PMID: 18694378
   PubMed Web of Science ®Google Scholar
• Holcomb B, Yip-Schneider M, Schmidt CM. The role of nuclear factor kappaB in pancreatic cancer and the clinical applications of targeted therapy. Pancreas 2008; 36:225 - 35; http://dx.doi.org/10.1097/MPA.0b013e31815b3207; PMID: 18362834
   PubMed Web of Science ®Google Scholar
• Hernández E, De La Mota-Peynado A, Dharmawardhane S, Vlaar CP. Novel inhibitors of Rac1 in metastatic breast cancer. P R Health Sci J 2010; 29:348 - 56; PMID: 21261173
   PubMed Web of Science ®Google Scholar
• Shutes A, Onesto C, Picard V, Leblond B, Schweighoffer F, Der CJ. Specificity and mechanism of action of EHT 1864, a novel small molecule inhibitor of Rac family small GTPases. J Biol Chem 2007; 282:35666 - 78; http://dx.doi.org/10.1074/jbc.M703571200; PMID: 17932039
   PubMed Web of Science ®Google Scholar
• Onesto C, Shutes A, Picard V, Schweighoffer F, Der CJ. Characterization of EHT 1864, a novel small molecule inhibitor of Rac family small GTPases. Methods Enzymol 2008; 439:111 - 29; http://dx.doi.org/10.1016/S0076-6879(07)00409-0; PMID: 18374160
   PubMed Web of Science ®Google Scholar
• Désiré L, Bourdin J, Loiseau N, Peillon H, Picard V, De Oliveira C, et al. RAC1 inhibition targets amyloid precursor protein processing by gamma-secretase and decreases Abeta production in vitro and in vivo. J Biol Chem 2005; 280:37516 - 25; http://dx.doi.org/10.1074/jbc.M507913200; PMID: 16150730
   PubMed Web of Science ®Google Scholar
• Strassheim D, Shafer SH, Phelps SH, Williams CL. Small cell lung carcinoma exhibits greater phospholipase C-beta1 expression and edelfosine resistance compared with non-small cell lung carcinoma. Cancer Res 2000; 60:2730 - 6; PMID: 10825148
   PubMed Web of Science ®Google Scholar
• Varker KA, Williams CL. Involvement of the muscarinic acetylcholine receptor in inhibition of cell migration. Biochem Pharmacol 2002; 63:597 - 605; http://dx.doi.org/10.1016/S0006-2952(01)00901-7; PMID: 11992627
   PubMed Web of Science ®Google Scholar